Wird geladen...
Connexin43 peptide, TAT-Cx43(266–283), selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo
BACKGROUND: Malignant gliomas are the most frequent primary brain tumors and remain among the most incurable cancers. Although the role of the gap junction protein, connexin43 (Cx43), has been deeply investigated in malignant gliomas, no compounds have been reported with the ability to recapitulate...
Gespeichert in:
| Veröffentlicht in: | Neuro Oncol |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7158688/ https://ncbi.nlm.nih.gov/pubmed/31883012 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz243 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|